Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filed with BSE · ISIN INE225B01021 · · 5 pages · English
Summary by 6ix AI
Fermenta Biotech Limited has issued a press release regarding its unaudited financial results for the first half of the fiscal year. The report indicates a decline in consolidated revenue and profit compared to the previous year, primarily due to lower sales in the animal nutrition segment. The Managing Director highlighted the growth in the human nutrition segment, which now constitutes a significant portion of overall revenue.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Fermenta Biotech
- Intimation Regarding The Board'S Decision To Close The Company'S Wholly-Owned Subsidiary - Fermenta Biotech (UK) Limited.
- Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results For Quarter Ended September 30, 2026.
- Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended September 30, 2026.
- Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For Quarter And Half Year Ended September 30, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Follow Fermenta Biotech into a list and get an email when it puts out news.
Follow Fermenta Biotech